ERVK-20, endogenous retrovirus group K member 20, 100616444
N. diseases: 143; N. variants: 0
Source: ALL
| Disease | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year |
|---|---|---|---|---|---|---|---|
|
|
0.070 | GeneticVariation | disease | BEFREE | Phylogenetic analysis of the env gene showed that all the Cuban sequences clustered in group A of HIV-2. | 24925342 | 2014 |
|
|
0.070 | Biomarker | disease | BEFREE | In the present case study, we attempted to observe amino acid substitutions in Gag and Env proteins and related parameters possibly associated with an increase in HIV-2 load. | 18622680 | 2008 |
|
|
0.070 | Biomarker | disease | BEFREE | The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? | 8551620 | 1996 |
|
|
0.070 | Biomarker | disease | BEFREE | The V3 and V4 domains of human immunodeficiency virus type 2 (HIV-2) env genes from 14 rhesus macaques experimentally infected by HIV-2 SBL6669/H5 were sequenced. | 8151803 | 1994 |
|
|
0.070 | Biomarker | disease | BEFREE | Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses. | 8480426 | 1993 |
|
|
0.070 | Biomarker | disease | BEFREE | To investigate the glycoprotein determinants of viral cytopathology, we constructed chimeric env genes between a noncytopathic strain of human immunodeficiency virus type 2 (HIV-2), designated HIV-2/ST, and a highly fusogenic and cytopathic variant derived from this virus. | 1583738 | 1992 |
|
|
0.070 | Biomarker | disease | BEFREE | Dimerization of the envelope glycoprotein precursor and dimeric forms of the transmembrane glycoproteins were also observed in cells infected with simian immunodeficiency virus (SIV-mac), a virus closely related to HIV-2. | 2296088 | 1990 |